Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor

Details for Australian Patent Application No. 2007235576 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Mapes, Christopher M.; Kindrachuk, David E.; Edwards, James P.; Pippel, Daniel J.; Venable, Jennifer D.

Agent Shelston IP

Pub. Number AU-B-2007235576

PCT Pub. Number WO2007/117399

Priority 60/788,190 31.03.06 US

Filing date 30 March 2007

Wipo publication date 18 October 2007

Acceptance publication date 10 November 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4184 (2006.01)

C07D 239/47 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/117399 Priority application(s): WO2007/117399

10 November 2011 Application Accepted

  Published as AU-B-2007235576

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007235577-Benzoimidazol-2-yl pyridines as modulators of the histamine H4 receptor

2007235575-Non-peptidic molecules for detecting and treating tumors